Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin) von LARSON, R. A, BOOGAERTS, M, MUNTEANU, M, LOKEN, M. R, VAN DONGEN, J. J. M, BERNSTEIN, I. D, APPELBAUM, F. R, ESTEY, E, KARANES, C, STADTMAUER, E. A, SIEVERS, E. L, MINEUR, P, BENNETT, J. M, BERGER, M. S, ETEN, C. B

Volltext

A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma von CHAN, Stephen Y, GORDON, Alan N, COLEMAN, Robert E, HALL, James B, BERGER, Mark S, SHERMAN, Matthew L, ETEN, Catharine B, FINKLER, Neil J

Volltext

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse von SIEVERS, Eric L, LARSON, Richard A, BERGER, Mark S, ETEN, Catharine B, LOKEN, Michael R, VAN DONGEN, Jacques J. M, BERNSTEIN, Irwin D, APPELBAUM, Frederick R, STADTMAUER, Edward A, ESTEY, Elihu, LÖWENBERG, Bob, DOMBRET, Hervé, KARANES, Chatchada, THEOBALD, Matthias, BENNETT, John M, SHERMAN, Matthew L

Volltext